Loss-of-function variants in LZTR1 likely remove a critical checkpoint in this pathway, contributing to a spectrum of features including mild dysmorphisms and cardiac anomalies, although with a reduced prevalence of hypertrophic cardiomyopathy compared to RAF1 or PTPN11 [36,40]. The gene discussed is RAF1; the disease is hypertrophic cardiomyopathy.